The landscape of dementia prognosis has developed drastically with the advent of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. While these technological innovations characterize exceptional progress in being familiar with neurodegenerative https://timc197doy8.wikinarration.com/user